In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
Freenome retains rights to its CRC blood test when combined with other cancer screening tests. Credit: PeopleImages.com - Yuri A / Shutterstock.com. · Medical Device Network · PeopleImages.com - Yuri ...
Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...
MADISON, Wis., April 28, 2021 /PRNewswire/ -- Exact Sciences (NASDAQ: EXAS) today announces study results published in Mayo Clinic Proceedings showing that Cologuard (mt-sDNA) is the most ...
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy Inc., a life sciences company focused on developing diagnostic tests for gastrointestinal health, announced a publication in The Journal of the American Medical ...
BRISBANE, Calif., July 9, 2026 /PRNewswire/ -- Freenome, an early cancer detection company developing blood-based screening tests, today announced favorable results from its pivotal clinical ...
SimpleScreen CRC is a new FDA-approved blood test that screens for colorectal cancer. Patients can ask their doctor to order the test, have their blood drawn at the office, and receive results in ...
Colorectal cancer screening preferences differ across underserved populations, suggesting that aligning screening options with patient preferences may help improve screening uptake and adherence. A ...
While screening for colorectal cancer (CRC) with a blood-based test would result in better outcomes than no screening at all, it would likely result in worse outcomes than currently available tests -- ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Freenome, the privately held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection using a routine blood ...
Please provide your email address to receive an email when new articles are posted on . Newly available noninvasive colorectal cancer tests have opened the doors to an uptick in screening, especially ...